Benzinga · Jan 30, 2026

NYSE · CCM
Concord Medical Services Holdings Limited
Healthcare · Medical - Care Facilities
$3.97
Up+$0.02 (+0.51%)
Updated Sep 12, 2026, 7:36 PM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 649.44K
- P/E ratio
- -0.03
- Dividend yield
- 0.00%
- 52-week range
- $3.18 – $6.98
- Volume
- 3.23K
- Avg. volume
- 16.05K
Price performance
CCM price history
1M range · 20 trading sessions · Daily adjusted prices
CCM closed at $3.97 after 20 trading sessions, down 16.60% for the selected period.
- Last close
- $3.97
- Period change
- -16.60%
- Period low
- $3.95
- Period high
- $5.29
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $3.98 | $4.25 | $3.95 | $3.97 | 3.23K |
| Sep 10, 2026 | $4.09 | $4.11 | $3.95 | $3.95 | 4.08K |
| Sep 9, 2026 | $4.30 | $4.33 | $4.11 | $4.12 | 7.58K |
| Sep 8, 2026 | $4.67 | $4.67 | $3.9655 | $4.35 | 12.88K |
| Sep 4, 2026 | $4.57 | $4.68 | $4.40 | $4.68 | 11.1K |
| Sep 3, 2026 | $4.70 | $4.70 | $4.455 | $4.455 | 1.25K |
| Sep 2, 2026 | $4.52 | $5.01 | $4.51 | $4.65 | 90.03K |
| Sep 1, 2026 | $4.50 | $4.785 | $4.48 | $4.52 | 140.47K |
| Aug 31, 2026 | $4.65 | $4.65 | $4.42 | $4.56 | 25.67K |
| Aug 28, 2026 | $4.95 | $4.95 | $4.57 | $4.76 | 37.23K |
| Aug 27, 2026 | $5.025 | $5.05 | $4.78 | $4.90 | 153.69K |
| Aug 26, 2026 | $4.94 | $5.44 | $4.78 | $4.96 | 150.84K |
| Aug 25, 2026 | $5.06 | $5.06 | $4.95 | $4.95 | 9.4K |
| Aug 24, 2026 | $5.23 | $5.36 | $4.90 | $4.98 | 68.91K |
| Aug 21, 2026 | $5.1083 | $5.52 | $5.07 | $5.29 | 27.72K |
| Aug 20, 2026 | $4.88 | $5.3899 | $4.845 | $5.25 | 137.83K |
| Aug 19, 2026 | $4.43 | $5.06 | $4.43 | $4.80 | 63.99K |
| Aug 18, 2026 | $4.61 | $4.89 | $4.41 | $4.57 | 173.49K |
| Aug 17, 2026 | $4.91 | $5.275 | $4.61 | $4.66 | 258.09K |
| Aug 14, 2026 | $4.62 | $5.07 | $4.56 | $4.76 | 517.48K |
Latest CCM news
The latest Smart Investors Daily articles mentioning CCM.
Stock researchCompany · Overview
CCM research
Overview
Company profile and research snapshot.
Company profile
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
prnewswire.com · Dec 2, 2025
Concord Medical Schedules 2025 Annual Meeting of Shareholders
BEIJING , Dec. 2, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it will hold its 2025 annual general meeting of shareholders (the "Meeting") on December 29, 2025, at 10:00 a.m. (Beijing Time).
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.

